The short answer
"Triple-negative" describes a breast cancer that tests negative for three receptors: estrogen receptor (ER), progesterone receptor (PR), and HER2. Because it lacks these targets, hormone therapy and HER2-targeted drugs generally don't work. Surgery, chemotherapy, immunotherapy and, for some people, PARP inhibitors are the main options. It describes the cancer's biology, not its stage, and effective treatments exist.
Triple-negative = negative for ER, PR, and HER2 on testing.
Hormone therapy and HER2-targeted drugs usually aren't options because those targets are absent.
Chemotherapy is a mainstay; immunotherapy and other treatments may be options depending on the situation.
It describes biology, not stage — triple-negative cancers can be early or advanced.
On this page
Choose how you want to read this
The whole article, with every detail and caution.
Where you'll see this phrase
You'll see this phrase on a breast cancer pathology report. It comes after receptor testing. It might read "ER negative, PR negative, HER2 negative — triple-negative breast cancer." This is often shortened to TNBC.
What it means in plain language
Doctors test breast cancers for three things. Treatment can target all three: the estrogen receptor, the progesterone receptor, and HER2, a growth-related protein. When all three come back absent, the cancer is called triple-negative. It simply lacks these particular targets.
Why it matters
These three receptors matter because certain drugs are built to act on them. Without the receptors, hormone therapy and HER2-targeted drugs are not expected to work. That is why triple-negative cancers are treated mainly with chemotherapy. Depending on your situation, immunotherapy, drugs for specific mutations, or a clinical trial may also be options.
An immunotherapy option
The American Cancer Society lists the immunotherapy drug pembrolizumab as one treatment for triple-negative breast cancer. Whether it is right for you depends on your stage and your situation. Ask your oncologist whether you qualify and when it would be given. Not everyone does.
What it does not mean
Triple-negative does not mean "untreatable." Effective treatments exist. Research in this area is active. It also does not describe the stage of the cancer. Triple-negative cancers can be caught early too. The American Cancer Society reports 5-year relative survival of 92% when the cancer is found while still localized, 67% when regional and 15% when distant (diagnoses 2015 to 2021). People diagnosed now probably have a better outlook than these older numbers show.
The BRCA connection
Triple-negative breast cancer is more common in people who carry an inherited BRCA1 mutation. Because of this link, genetic testing may be right for some people. Ask your team whether it applies to you. For BRCA-positive cancers, PARP inhibitors are one treatment option.
What context is still needed
Triple-negative is a description of biology, not a full plan. Your actual treatment depends on stage, grade, genetic testing, and your overall health. Your oncologist puts all of this together with you.
Is this urgent?
A triple-negative diagnosis is not an emergency by itself. Because this cancer can grow faster, ask your team for a treatment timeline. Do not wait without an answer. If you have a fever of 100.4 F (38 C) or higher during chemotherapy, call your care team right away. For chest pain or severe trouble breathing, call 911.
What to ask your team
- What treatments are recommended for my triple-negative cancer, and why?
- Am I a candidate for immunotherapy, and at what point in my treatment?
- Should I have genetic testing, including for BRCA mutations?
- How soon should treatment start?
Clinical trials are worth asking about
Ask your oncologist whether any clinical trials are open for your situation, at diagnosis or if the cancer returns.
How treatment response is tracked
For cancer treated before surgery, doctors check how much cancer remains in the removed tissue. A pathologic complete response means no invasive cancer is found there. FDA guidance says people with this result tend to have a better outlook than those with leftover cancer. Leftover cancer can change the next steps, so ask your team what the surgical pathology report means for you.
Sources

Common questions
Is triple-negative breast cancer always aggressive?
The American Cancer Society says triple-negative cancer tends to grow and spread faster than most other invasive breast cancers. It varies a lot from person to person. Stage and how the cancer responds to treatment matter, and many people are treated successfully.
Why can't I take hormone therapy?
Hormone therapies work by blocking estrogen or progesterone signals. If the cancer is ER- and PR-negative, there's no receptor for those drugs to act on, so they aren't expected to help.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Your next step
Plain-language definitions for the words on your report.
Talk with a trained specialist or navigator
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Fever of 100.4°F (38°C) or higher during chemo, severe pain, or trouble breathing: call your cancer care team right away, day or night. Call 911 for an emergency.
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Last updated: 2026-10-02Next planned review: 2027-07-12
Review details and limits
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Source checked. This page was written with AI assistance and then compared with the sources listed on it, looking for statements those sources do not back up. That check is not a sentence-by-sentence record and can miss errors. It is not a medical review, and it does not confirm the page is complete or right for your situation.
General education. Low-risk educational or organizational content. Medical facts are cited to authoritative sources.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Words to know
Tap any term to see what it means.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Source checked — This page was written with AI assistance and then compared with the sources listed on it, looking for statements those sources do not back up. That check is not a sentence-by-sentence record and can miss errors. It is not a medical review, and it does not confirm the page is complete or right for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
